Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Bcrx crawled time : 12:01 save search
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2021-02-02 (Crawled : 12:01) - globenewswire.com
BCRX | $4.44 -1.33% -1.35% 4.7M
|
Health Technology
|
| O: 7.93%
H: 0.86%
C: -17.67%
granted grant
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2021-01-07 (Crawled : 12:01) - globenewswire.com
BCRX | $4.44 -1.33% -1.35% 4.7M
|
Health Technology
|
| O: 2.78%
H: 1.68%
C: -0.26%
granted grant
BioCryst Announces Positive Phase 1 Results with BCX9250, an Oral ALK-2 Inhibitor for Treatment of Fibrodysplasia Ossificans Progressiva
Published: 2020-12-21 (Crawled : 12:01) - globenewswire.com
BCRX | $4.44 -1.33% -1.35% 4.7M
|
Health Technology
|
| O: 0.58%
H: 0.75%
C: -4.16%
results positive treatment phase 3 phase 1 phase 2
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.